title: Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
authors.forename: R
authors.initials: R
authors.lastname: Colebunders
authors.forename: E
authors.initials: E
authors.lastname: Florence
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003906:Developing Countries; D004359:Drug Therapy, Combination; D015497:HIV-1; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D014376:Tuberculosis / Q000517:prevention & control*
chemical_list: D000995:Antitubercular Agents; D011718:Pyrazinamide; D007538:Isoniazid; D012293:Rifampin